BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Four Pharma Company Stocks Debut on Nasdaq This Morning

  Multiple pharma company stocks make their first appearance on the Nasdaq this morning to advance the next-generation therapeutics. BioSpace takes a look at some of these IPOs.

  June 25, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Pharm Country

  Pfizer Pauses Global Sales of Smoking-Cessation Drug Chantix Over Possible Carcinogen Contamination

  The company indicated it was pausing distribution out of an abundance of caution and would continue investigations.

  June 25, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Mirati Grabs Breakthrough Therapy Designation for KRAS inhibitor

  The U.S. Food and Drug Administration (FDA) has made the decision to grant Breakthrough Therapy Designation to Mirati Therapeutics’ adagrasib for the potential treatment of non-small cell lung cancer (NSCLC) in patients harboring the KRASG12C mutation after systemic therapy.

  June 25, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  Drug Development

  Roche Scores Wins in AMD & COVID-19 in Big Week

  Roche had a big week, scoring wins but also stepping away from its gene therapy partnership with 4D Molecular Therapeutics.

  June 25, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Policy

  FDA Action Alert: Vericel and Provention Bio

  Ahead of the July Fourth holiday, the U.S. Food and Drug Administration has two PDUFA dates on the calendar. Here’s a look.

  June 25, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Clinical Catch-Up: June 21-25

  It was a busy week for clinical trial news. Here’s a look.

  June 25, 2021

   · 

  11 min read

   · 

  Mark Terry
• 

  Biotech Bay

  US, China Biotechs Report Promising Results in Cancer Research for mTORC1 and IN10018

  It’s been a week of promising news for cancer research, with two possible treatment modalities reporting positive results.

  June 25, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Pharm Country

  How a New Class of Cancer Drug Could Stop Future Coronaviruses

  A new class of compounds currently in development against acute myeloid leukemia has been discovered to block coronavirus reproduction in human lung cells.

  June 25, 2021

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Policy

  New Info Continues to Feed Lab-Leak COVID-19 Theories, at Least Circumstantially

  New data continues to emerge that seems to add to the possibility of COVID-19 originating from a lab leak at China’s Wuhan Institute of Virology.

  June 25, 2021

   · 

  7 min read

   · 

  Mark Terry
• 

  Drug Development

  Will Intellia Make Gene Editing History Saturday?

  In what will be a big moment for CRISPR technology, Intellia and development partner, Regeneron Pharmaceuticals will share the world’s first data from a therapy that edits flawed genes inside the body.

  June 25, 2021

   · 

  2 min read

   · 

  Heather McKenzie